Research Services
Bagamian Scientific Consulting’s experts can help you plan and conduct your research.
Our team has conducted research projects for various nonprofit public and global health organizations, as well as for pharmaceutical companies. Our team consists of quantitative, qualitative, and mixed methods researchers who have a broad range of expertise and experience.
Let us help you with that project that you are ready to get off of your To Do list!
“Dr. Bagamian gave me advice on equipment, reagents, protocols, and advised my grad student on various lab and field techniques, such as qRT-PCR and large-scale field enclosures. I will definitely use Bagamian Scientific Consulting again!”
─ Associate Professor in Disease Ecology
Case Study
PATH’s Shigella Vaccine Public Health Value Proposition
The Bagamian Sci team contributed to PATH’s Shigella vaccine public health value proposition, which comprehensively considered the potential impact of Shigella vaccines globally and at the national stakeholder level.
Shigella is a leading bacterial cause of diarrhea in children from certain low-to-middle-income countries and military and international travelers. Shigella infections are associated with downstream child growth deficits (known as stunting) which have been linked to physical and cognitive delays and reduced adulthood productivity. Although still in the later stages of clinical development, a Shigella vaccine can potentially save lives and improve immediate and downstream child health outcomes.
As part of this project, the Bagamian Sci team completed the following:
- Synthesized the available literature about the potential child growth impacts of Shigella infection and prepared a review, published in the journal Vaccine: X.
- Contributed to and developed a peer-reviewed publication summarizing the proceedings of an expert meeting on child growth impacts of Shigella infection and the potential impacts.
- Generated cost-effectiveness models of Shigella vaccine candidates, which included the benefits gained by reducing Shigella diarrhea and Shigella-attributable stunting. This study was published in The Lancet Global Health.
- Coauthored WHO Vaccine Value profiles on potential ETEC and Shigella vaccines, published as a series in Vaccine.
